AMBU APPOINTS NEW PRESIDENT OF NORTH AMERICA REGION

Effective 25 August 2025, Ambu announces the appointment of Scott Heinzelman as President of the North America commercial region. He succeeds Steven Block, who has decided to step down after 12 years of dedicated leadership to begin a new chapter in semi-retirement.

Scott Heinzelman is a seasoned commercial executive with extensive experience in driving strong growth and organizational transformation. He is a US native with more than two decades of experience from the medtech industry, having held senior leadership roles at global healthcare companies, such as Abbott, Orthofix, and Covidien (now Medtronic). Most recently, he served as Divisional Vice President of Abbott Vascular’s US Commercial business, where he led a $1 billion organization, built a specialized sales force, launched breakthrough therapies, and delivered growth that outpaced the market. Prior to that, he held roles as Divisional Vice President of Sales & Marketing and Global Head of Commercial Excellence, with responsibility for commercial strategy, P&L performance, and commercial infrastructure.

Throughout his career, Scott has demonstrated a strong ability to shape commercial strategy, drive sustainable and profitable growth, and lead high-performing sales organizations with a sharp focus on execution across complex business environments. His leadership is characterized by strategic clarity, customer focus, and a collaborative mindset – qualities that have consistently delivered results and earned the trust of customers, colleagues, and partners alike.

“I am very excited to welcome Scott Heinzelman as our new President for Ambu North America. Scott brings a wealth of commercial experience and a proven ability to define and deliver a customer-focused high-growth agenda from leading medtech companies. His strong leadership skills, combined with his strategic and analytical capabilities, makes him a natural choice to lead our continued expansion and to strengthen our leadership position in the North American market. 

Also, I would like to thank Steven for leading our Ambu North America team over the past 12 years. He has played an instrumental role in driving a successful growth agenda and demonstrating strong leadership. I wish him all the best in his next life chapter.”

BRITT MEELBY JENSEN
Chief Executive Officer

Leading the next phase of growth in North America
Over the past decade, Ambu North America has achieved strong growth and is today a leading company in the US endoscopy market as well as a prominent player in the US medtech industry. The organization has an extensive presence in hospitals nationwide and contributes to improving care for millions of patients every year. Steven Block has played a central role in elevating Ambu’s North American business to this impactful position.

With a strong foundation established and Scott Heinzelman appointed as President, Ambu is well-positioned to accelerate its growth ambitions in the North American market. He will join Ambu’s Executive Leadership Team as he takes on the responsibility for leading the next phase of growth and leadership in North America.

“I'm honored to join this incredible organization at such an important time. Ambu has a history of customer-centric innovation and a strong culture; this is a winning formula for delivering strong results. It is a privilege to lead the North America organization into this next stage of high growth and profitability. Our focus is clear: deliver solutions that make a real difference in healthcare and patients’ lives. We’re not just aiming to grow – we’re aiming to lead.” 

SCOTT HEINZELMAN
New President, Ambu North America